Organigram Global (OGI) Other Non-Current Assets (2018 - 2025)
Organigram Global (OGI) posted quarterly Other Non-Current Assets of $36.0 million for Q3 2025, up 20.59% year-over-year from $29.9 million in Q3 2024, and up 20.59% quarter-over-quarter from $29.9 million in Q3 2024.
Organigram Global (OGI) Other Non-Current Assets (2018 - 2025) Analysis & Trends
Organigram Global (OGI) has reported Other Non-Current Assets for 4 consecutive years, with $36.0 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Other Non-Current Assets rose 20.59% year-over-year to $36.0 million; the TTM figure through Sep 2025 stood at $36.0 million (up 20.59% YoY), while the FY2025 annual figure was $36.0 million, up 20.59% from the prior year.
- Other Non-Current Assets advanced to $36.0 million in Q3 2025 per OGI's latest filing, from $29.9 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $36.0 million in Q3 2025 and bottomed at $13.3 million in Q3 2023.
- Historically, Other Non-Current Assets has averaged $26.4 million across 3 years, with a median of $29.9 million in 2024.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets soared 123.68% — and 2025, when it climbed 20.59%.
- Organigram Global's Other Non-Current Assets stood at $13.3 million in 2023, then jumped by 123.68% to $29.9 million in 2024, then increased by 20.59% to $36.0 million in 2025.
- Business Quant data shows OGI's Other Non-Current Assets at $36.0 million in Q3 2025, $29.9 million in Q3 2024, and $13.3 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 13.00 Mn |
| 10 | Organigram Global | 150.66 Mn | 150.54 Mn | 28.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 36.00 Mn |
| Sep 30, 2024 | 29.86 Mn |
| Sep 30, 2023 | 13.35 Mn |
| Aug 31, 2018 | 1.22 Mn |